Activiomics: Unlabeled proteomics

Activiomics' proteomics platform quantifies significant changes in human tissue

Most proteomics platforms that rely on labeling can only be used in cell lines and handle a small number of samples in any one experiment, making it difficult to quantify significant changes in cell signaling. In contrast, Activiomics Ltd.'s TIQUAS label-free proteomics software can be used in human tissue samples and can quantify statistically significant changes in kinase phosphorylation.

The result, according to the company, is more robust conclusions in biomarker

Read the full 708 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE